Cure My Disease

Don't miss your cure!

 Log in / Sign up

Sound waves vs. uterine pain: can HIFU calm adenomyosis?

NCT ID NCT07808034

Disease control Sponsor: Far Eastern Memorial Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 08, 2026 · Last updated Sep 09, 2026 · Updated 1 time

Summary

This trial tests whether MRI-guided High-Intensity Focused Ultrasound (HIFU) can ease symptoms of adenomyosis, a condition where uterine tissue grows into the muscle wall, causing pain and heavy bleeding. Researchers plan to enroll 20 women aged 18 and older who have adenomyosis with dysmenorrhea or menorrhagia. The procedure uses sound waves to heat and shrink the abnormal tissue without surgery. The study measures changes in pain, bleeding, bladder symptoms, sexual function, and bowel incontinence scores.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MRI-guided High-Intensity Focused Ultrasound (a procedure that uses sound waves to heat and shrink adenomyosis tissue)
What this could lead to
If it works, this could offer a non-surgical option for women with adenomyosis to reduce pain and heavy bleeding.
What could go wrong
This is a small, early trial with only 20 participants, so results may not apply broadly. The procedure carries risks like burns or damage to nearby organs, and it may not fully relieve symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 20 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Dec 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients with symptomatic uterine adenomyosis:

Ages

18 years and older

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. The patient must be at least 18 years old. 2. Adenomyosis: There must be several dark areas on at least one side of the uterine wall; the uterine wall must be thickened; in addition, the thickened uterine wall must have a nonhomogeneous structure; and clinically, there must be dysmenorrhea or menorrhagia. Exclusion Criteria: 1. The patient currently has an acute lower urinary tract infection or intestinal inflammation. 2. The patient has previously undergone bladder or urethral surgery. 3. The patient has a history of urinary tract stones or tumors.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adenomyosis of uterus are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

adenomyosis Lower Urinary Tract Symptoms physiological sexual disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Adenomyosis of uterus

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital

    Banqiao District, New Taipei, 22050, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.